Silverfin false false 31/01/2026 01/02/2025 31/01/2026 A Coleman 20/07/2020 N Coleman 06/07/2010 P Paul 17/02/2026 15/03/2021 E Silva 20/07/2020 U Silva 06/07/2010 L Wilcox 17/01/2018 17 July 2026 no description of principal activity 07305206 2026-01-31 07305206 bus:Director1 2026-01-31 07305206 bus:Director2 2026-01-31 07305206 bus:Director3 2026-01-31 07305206 bus:Director4 2026-01-31 07305206 bus:Director5 2026-01-31 07305206 bus:Director6 2026-01-31 07305206 2025-01-31 07305206 core:CurrentFinancialInstruments 2026-01-31 07305206 core:CurrentFinancialInstruments 2025-01-31 07305206 core:ShareCapital 2026-01-31 07305206 core:ShareCapital 2025-01-31 07305206 core:SharePremium 2026-01-31 07305206 core:SharePremium 2025-01-31 07305206 core:RetainedEarningsAccumulatedLosses 2026-01-31 07305206 core:RetainedEarningsAccumulatedLosses 2025-01-31 07305206 core:OtherResidualIntangibleAssets 2025-01-31 07305206 core:OtherResidualIntangibleAssets 2026-01-31 07305206 core:PlantMachinery 2025-01-31 07305206 core:Vehicles 2025-01-31 07305206 core:PlantMachinery 2026-01-31 07305206 core:Vehicles 2026-01-31 07305206 2024-01-31 07305206 core:AcceleratedTaxDepreciationDeferredTax 2026-01-31 07305206 core:AcceleratedTaxDepreciationDeferredTax 2025-01-31 07305206 core:TaxLossesCarry-forwardsDeferredTax 2026-01-31 07305206 core:TaxLossesCarry-forwardsDeferredTax 2025-01-31 07305206 bus:OrdinaryShareClass1 2026-01-31 07305206 bus:OrdinaryShareClass2 2026-01-31 07305206 bus:OrdinaryShareClass3 2026-01-31 07305206 bus:OrdinaryShareClass4 2026-01-31 07305206 bus:OrdinaryShareClass5 2026-01-31 07305206 bus:OtherShareClass1 2026-01-31 07305206 core:WithinOneYear 2026-01-31 07305206 core:WithinOneYear 2025-01-31 07305206 core:BetweenOneFiveYears 2026-01-31 07305206 core:BetweenOneFiveYears 2025-01-31 07305206 2025-02-01 2026-01-31 07305206 bus:FilletedAccounts 2025-02-01 2026-01-31 07305206 bus:SmallEntities 2025-02-01 2026-01-31 07305206 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 07305206 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 07305206 bus:Director1 2025-02-01 2026-01-31 07305206 bus:Director2 2025-02-01 2026-01-31 07305206 bus:Director3 2025-02-01 2026-01-31 07305206 bus:Director4 2025-02-01 2026-01-31 07305206 bus:Director5 2025-02-01 2026-01-31 07305206 bus:Director6 2025-02-01 2026-01-31 07305206 core:OtherResidualIntangibleAssets core:TopRangeValue 2025-02-01 2026-01-31 07305206 core:PlantMachinery core:TopRangeValue 2025-02-01 2026-01-31 07305206 core:PlantMachinery 2025-02-01 2026-01-31 07305206 core:Vehicles core:TopRangeValue 2025-02-01 2026-01-31 07305206 2024-02-01 2025-01-31 07305206 core:OtherResidualIntangibleAssets 2025-02-01 2026-01-31 07305206 core:Vehicles 2025-02-01 2026-01-31 07305206 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 07305206 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 07305206 bus:OrdinaryShareClass2 2025-02-01 2026-01-31 07305206 bus:OrdinaryShareClass2 2024-02-01 2025-01-31 07305206 bus:OrdinaryShareClass3 2025-02-01 2026-01-31 07305206 bus:OrdinaryShareClass3 2024-02-01 2025-01-31 07305206 bus:OrdinaryShareClass4 2025-02-01 2026-01-31 07305206 bus:OrdinaryShareClass4 2024-02-01 2025-01-31 07305206 bus:OrdinaryShareClass5 2025-02-01 2026-01-31 07305206 bus:OrdinaryShareClass5 2024-02-01 2025-01-31 07305206 bus:OtherShareClass1 2025-02-01 2026-01-31 07305206 bus:OtherShareClass1 2024-02-01 2025-01-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 07305206 (England and Wales)

PROCURE HEALTH LIMITED

Unaudited Financial Statements
For the financial year ended 31 January 2026
Pages for filing with the registrar

PROCURE HEALTH LIMITED

Unaudited Financial Statements

For the financial year ended 31 January 2026

Contents

PROCURE HEALTH LIMITED

BALANCE SHEET

As at 31 January 2026
PROCURE HEALTH LIMITED

BALANCE SHEET (continued)

As at 31 January 2026
Note 2026 2025
£ £
Fixed assets
Intangible assets 3 59,257 62,953
Tangible assets 4 50,507 39,027
109,764 101,980
Current assets
Stocks 5 428,059 393,183
Debtors 6 716,337 850,174
Cash at bank and in hand 7 31,124 111,344
1,175,520 1,354,701
Creditors: amounts falling due within one year 8 ( 1,162,480) ( 1,240,485)
Net current assets 13,040 114,216
Total assets less current liabilities 122,804 216,196
Provision for liabilities 9 ( 155) ( 9,757)
Net assets 122,649 206,439
Capital and reserves
Called-up share capital 10 105 105
Share premium account 43,690 39,956
Profit and loss account 78,854 166,378
Total shareholders' funds 122,649 206,439

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Procure Health Limited (registered number: 07305206) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

L Wilcox
Director

17 July 2026

PROCURE HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
PROCURE HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Procure Health Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Unit 5 Farmbrough Close, Aylesbury, HP20 1DQ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the sale of goods is recognised when the goods are physically delivered to the customer.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets is reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 10 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 4 years straight line
10 % reducing balance
Vehicles 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including directors 18 20

3. Intangible assets

Other intangible assets Total
£ £
Cost
At 01 February 2025 84,554 84,554
Additions 6,062 6,062
At 31 January 2026 90,616 90,616
Accumulated amortisation
At 01 February 2025 21,601 21,601
Charge for the financial year 9,758 9,758
At 31 January 2026 31,359 31,359
Net book value
At 31 January 2026 59,257 59,257
At 31 January 2025 62,953 62,953

4. Tangible assets

Plant and machinery Vehicles Total
£ £ £
Cost
At 01 February 2025 128,883 40,458 169,341
Additions 3,198 30,818 34,016
At 31 January 2026 132,081 71,276 203,357
Accumulated depreciation
At 01 February 2025 99,167 31,147 130,314
Charge for the financial year 13,633 8,903 22,536
At 31 January 2026 112,800 40,050 152,850
Net book value
At 31 January 2026 19,281 31,226 50,507
At 31 January 2025 29,716 9,311 39,027

5. Stocks

2026 2025
£ £
Stocks 428,059 393,183

6. Debtors

2026 2025
£ £
Trade debtors 643,457 786,489
Deferred tax asset 7,945 0
Corporation tax 11,090 0
Other debtors 53,845 63,685
716,337 850,174

7. Cash and cash equivalents

2026 2025
£ £
Cash at bank and in hand 31,124 111,344

8. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 795,443 743,955
Accruals 38,172 19,853
Corporation tax 0 10,817
Other taxation and social security 69,416 40,105
Other creditors 259,449 425,755
1,162,480 1,240,485

9. Deferred tax

2026 2025
£ £
At the beginning of financial year ( 9,757) ( 12,222)
Credited to the Profit and Loss Account 17,547 2,465
At the end of financial year 7,790 ( 9,757)

The deferred taxation balance is made up as follows:

2026 2025
£ £
Accelerated capital allowances ( 12,930) ( 9,757)
Tax losses carry forward 20,720 0
7,790 ( 9,757)

10. Called-up share capital

2026 2025
£ £
Allotted, called-up and fully-paid
2,777 A ordinary shares of £ 0.001 each 3 3
2,141 B ordinary shares of £ 0.001 each (2025: 1,794 shares of £ 0.001 each) 2 2
35,000 C ordinary shares of £ 0.001 each 35 35
15,000 D ordinary shares of £ 0.001 each 15 15
35,000 E ordinary shares of £ 0.001 each 35 35
15,000 F ordinary shares of £ 0.001 each 15 15
105 105

During the year, the Company issued 377 Ordinary B shares with a nominal value of £0.001 each for a total consideration of £3,734.

11. Financial commitments

Commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2026 2025
£ £
Within one year 117,260 44,434
Between one and five years 445,149 0
562,409 44,434

Pensions

The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £11,489 (2025: £11,621).

2026 2025
£ £
Unpaid contributions due to the fund (inc. in other creditors) 2,072 2,151